Article info
Review
Biomarkers and surrogate endpoints in glaucoma clinical trials
- Correspondence to Professor Felipe A Medeiros, Department of Ophthalmology, Hamilton Glaucoma Center, University of California, San Diego, 9500 Gilman Drive, La Jolla, CA 92093, USA; fmedeiros{at}ucsd.edu
Citation
Biomarkers and surrogate endpoints in glaucoma clinical trials
Publication history
- Received May 15, 2014
- Accepted June 28, 2014
- First published July 17, 2014.
Online issue publication
March 22, 2016
Article Versions
- Previous version (22 March 2016).
- You are viewing the most recent version of this article.
Request permissions
If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.
Copyright information
Published by the BMJ Publishing Group Limited. For permission to use (where not already granted under a licence) please go to http://group.bmj.com/group/rights-licensing/permissions